A Survey on Coronary Artery Disease Treatment in Bangladesh

Abstract

Coronary heart disease occurs when an accumulation of fatty substances in the coronary arteries obstructs or interrupts the blood flow to the heart. The arterial walls may eventually accumulate fatty deposits. The purpose of this research was to examine the treatment options for coronary artery disease in Bangladesh. The research was conducted through a survey of prescriptions. This investigation compiled a database of 190 coronary artery disease patients. Antiplatelet pharmaceuticals (60%), anticoagulants (20%), vasodilators (10%), and a combination of all three classes (10%) are the classes of drugs used to treat coronary artery disease (CAD) in Bangladesh, according to this study. Bangladesh has the highest incidence of CVD risk factors among South Asian countries. In Bangladesh, 99.6% of men and 97.9% of women are exposed to one or more known cardiovascular disease (CVD) risk factors.